Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity

被引：0
|
作者：
Rosenstock, Julio
Coskun, Tamer
Hartman, Mark L.
Lou, Jitong
Wu, Qiwei
Du, Yu
Gurbuz, Sirel
Mather, Kieren J.
Milicevic, Zvonko
Thomas, Melissa K.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-266-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
266-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Retatrutide, an agonist of GIP, GLP-1, and glucagon receptors, improves markers of pancreatic beta cell function and insulin sensitivity
    Thomas, M. K.
    Rosenstock, J.
    Coskun, T.
    Hartman, M. L.
    Lou, J.
    Wu, Q.
    Du, Y.
    Gurbuz, S.
    Mather, K.
    Milicevic, Z.
    DIABETOLOGIA, 2024, 67 : S72 - S73
  • [2] Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients
    Thomas, Melissa K.
    Nikooienejad, Amir
    Bray, Ross
    Cui, Xuewei
    Wilson, Jonathan M.
    Duffin, Kevin L.
    Milicevic, Zvonko
    Haupt, Axel
    Robins, Deborah A.
    DIABETES, 2019, 68
  • [3] TIRZEPATIDE, A DUAL GIP AND GLP-1 RECEPTOR AGONIST, INCREASES INSULIN SENSITIVITY AND IMPROVES PANCREATIC BETA-CELL FUNCTION IN TYPE 2 DIABETES
    Pirro, V.
    Nikooienejad, A.
    Lin, Y.
    Willency, J.
    Wilson, J.
    Duffin, K.
    Robins, D.
    Milicevic, Z.
    Haupt, A.
    Thomas, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A165 - A165
  • [4] Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
    Thomas, Melissa K.
    Nikooienejad, Amir
    Bray, Ross
    Cui, Xuewei
    Wilson, Jonathan
    Duffin, Kevin
    Milicevic, Zvonko
    Haupt, Axel
    Robins, Deborah A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02): : 388 - 396
  • [5] A TRIGONAL GLP-1, GIP AND GLUCAGON RECEPTOR AGONIST, RETATRUTIDE, AND METABOLIC SYNDROME
    Naeem, Hamza
    Akram, Sarah
    Rafique, Rida Ayesha
    Naeem, Ahsan
    Javed, Muhammad Abdullah
    Ali, Muhammad Mohsin
    Shehryar, Muhammad
    Umair, Muhammad
    Saeed, Mahnoor
    Bhatti, Hamza Sohail
    Randhawa, Fawad Ahmad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1936 - 1936
  • [6] Tirzepatide, a dual GIP and GLP-1 receptor agonist, improves markers of beta cell function and insulin sensitivity in type 2 diabetes patients
    Thomas, M. K.
    Nikooienejad, A.
    Bray, R.
    Cui, X.
    Wilson, J.
    Duffin, K.
    Milicevic, Z.
    Haupt, A.
    Robins, D. A.
    DIABETOLOGIA, 2019, 62 : S354 - S354
  • [7] Retatrutide, an agonist of GIP, GLP-1 and glucagon receptors, improves lipoprotein biomarkers associated with cardiovascular risk in participants with obesity or overweight
    Ruotolo, G.
    Pirro, V.
    Lin, Y.
    Wilson, J.
    Duffin, K.
    Zhen, E. Y.
    Harris, C.
    Thomas, M. K.
    Hartman, M. L.
    Coskun, T.
    Milicevic, Z.
    Haupt, A.
    Nicholls, S. J.
    DIABETOLOGIA, 2024, 67 : S353 - S354
  • [8] Lack of Synergy for Glucagon and GLP-1 on Acute Beta-Cell Function and Insulin Sensitivity in Mice
    Pacini, Giovanni
    Ahren, Bo
    DIABETES, 2014, 63 : A452 - A452
  • [9] The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
    Urva, Shweta
    O'Farrell, Libbey
    Du, Yu
    Loh, Mei Teng
    Hemmingway, Andrea
    Qu, Hongchang
    Alsina-Fernandez, Jorge
    Haupt, Axel
    Milicevic, Zvonko
    Coskun, Tamer
    DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2784 - 2788
  • [10] RETATRUTIDE, A TRIGONAL GLP-1, GIP AND GLUCAGON RECEPTOR AGONIST, AND ITS ROLE IN WEIGHT REDUCTION
    Naeem, Hamza
    Akram, Sarah
    Tarar, Rameez Akram
    Javed, Muhammad Abdullah
    Shahid, Muhammad Bilal
    Shehryar, Muhammad
    Rehman, Zia Ur
    Siddiqui, Muhammad Arshad
    Ayub, Shayan
    Irfan, Arslan
    Chaudhry, Muhammad Ali
    Randhawa, Fawad Ahmad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1902 - 1902
12345